Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ivan Hung and Tak-Lun Que.
Ivan Hung
Connection Strength
0.395
Tak-Lun Que
  1. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020 05 30; 395(10238):1695-1704.
    View in: PubMed
    Score: 0.220
  2. Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination. Clin Infect Dis. 2021 Jul 26.
    View in: PubMed
    Score: 0.060
  3. A Sensitive and Specific Competitive Enzyme-Linked Immunosorbent Assay for Serodiagnosis of COVID-19 in Animals. Microorganisms. 2021 May 10; 9(5).
    View in: PubMed
    Score: 0.059
  4. A Rapid, Simple, Inexpensive, and Mobile Colorimetric Assay COVID-19-LAMP for Mass On-Site Screening of COVID-19. Int J Mol Sci. 2020 Jul 29; 21(15).
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.